Sign in

CIK 0001721484

  • Emerging growth company

Longeveron Inc.

Sign in to watch
Ticker
LGVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472174146
Phone
+1 305-302-7158
Business address
1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
Former names
LONGEVERON LLC
  1. 4 Shares withheld for taxes General Counsel, Secretary gave up 3,247 shares (to pay taxes)
  2. 4 Shares withheld for taxes CFO and Treasurer gave up 3,247 shares (to pay taxes)
  3. 4 Shares withheld for taxes General Counsel, Secretary gave up 815 shares (to pay taxes)
  4. 4 Shares withheld for taxes CFO and Treasurer gave up 815 shares (to pay taxes)
  5. 4 Grant or award Chief Executive Officer acquired 50,000 shares (grant or award)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market sale Chief Scientific Officer sold 20,000 shares at $4.28 ($85,600)
  8. 5 Insider Annual Insider Trading Report
  9. 4 Shares withheld for taxes General Counsel, Secretary gave up 1,472 shares (to pay taxes)
  10. 4 Shares withheld for taxes CFO and Treasurer gave up 1,288 shares (to pay taxes)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market sale Chief Scientific Officer sold 20,000 shares at $3.74 ($74,800)

Page 9 of 13 · 246 filings